BioAtla (BCAB) Shares Outstanding (Entity) (2020 - 2026)
BioAtla (BCAB) Shares Outstanding (Entity) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 253.35 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 62.54 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 399.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 113.02 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 133.73 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 252.88 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 218.28 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 575.47 Mn |
| 10 | BioAtla | 5.41 Mn | 5.41 Mn | - | 1.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.66 Mn |
| Mar 31, 2026 | 1.66 Mn |
| Dec 31, 2025 | 1.27 Mn |
| Sep 30, 2025 | 1.18 Mn |
| Jun 30, 2025 | 1.17 Mn |
| Mar 31, 2025 | 1.17 Mn |
| Dec 31, 2024 | 1.16 Mn |
| Sep 30, 2024 | 966,911.00 |
| Jun 30, 2024 | 966,523.00 |
| Mar 31, 2024 | 962,126.00 |
| Dec 31, 2023 | 961,552.00 |
| Sep 30, 2023 | 958,148.00 |
| Jun 30, 2023 | 956,066.00 |
| Mar 31, 2023 | 952,746.00 |
| Dec 31, 2022 | 926,723.00 |
| Sep 30, 2022 | 727,306.00 |
| Jun 30, 2022 | 719,869.00 |
| Mar 31, 2022 | 717,826.00 |
| Dec 31, 2021 | 715,985.00 |
| Sep 30, 2021 | 703,809.00 |